iPhone | iPad
Android
Huawei
Savills Pakistan will offer services including sales, leasing and investment advisory, valuation, research and development, as well as project management.
Corporate2 weeks ago
KT APPDOWNLOAD
Yas Holding acquires pharma distributor Al Ittihad Drug Store
GlobalOne Healthcare, Yas Holding’s healthcare investment arm, completes the key acquisition
Abu Dhabi - GHH’s healthcare portfolio includes biopharma, manufacturing, medical supply chain, hospital and clinic management, healthcare technology, and occupational health and wellness
GlobalOne Healthcare Holding (GHH), a Yas Holding division, has announced the acquisition of a major UAE pharmaceutical distributor, Al Ittihad Drug Store (IDS), which will significantly expand GHH’s distribution coverage in the UAE.
The acquisition was completed in December, making GHH one of the largest medical distributors in the UAE.
“IDS provides a robust platform that complements our strengths in the pharmaceutical sector,” said Murshed Al Redaini, group chief executive officer of Yas Holding.
“This investment also underscores our commitment to the UAE Vision 2030 and is in line with our focus to establish a well-entrenched healthcare business. We are confident IDS’ business operations will synergise appreciably with our other healthcare companies,” he added.
IDS was established in 1968 and partners with leading multi-national corporations in the UAE to supply a diverse product portfolio across a range of therapeutic classes, including antibacterial, asthma, hypertension, diabetes, muscle relaxant, cardiovascular, anticoagulant, anti-rheumatic, and other classes.
Ashraf Radwan, the CEO of GHH, said: “We have a proven track record of creating significant long-term value by successfully integrating acquisitions into our growing portfolio of assets. This acquisition aligns with our overall strategy, since we view the business as an attractive opportunity offering substantial synergies.”
Suresh Vaidhyanathan, group CFO of Yas Holding, said, “Our ability to penetrate all consumer channels is a critical component of our healthcare value chain. IDS significantly enhances this capability along with a strong product portfolio that complements our growing ecosystem in healthcare.”
GHH has expanded considerably since its inception, with three earlier acquisitions also completed during 2021. The strategic acquisition of Gulf Inject, which was preceded by the addition of Geltec Healthcare and WellPharma Medical Solutions (WMS), further cemented GHH’s role as a key player in the regional healthcare landscape.
GHH’s healthcare portfolio includes biopharma, manufacturing, medical supply chain, hospital and clinic management, healthcare technology, and occupational health and wellness.
business@khaleejtimes.com
More news from Corporate
The total collections from Egypt in 2021 include a $48 million payment made by the Egyptian government in December
Corporate3 weeks ago
Dewa continues its efforts to provide a creative work environment with high productivity by providing its staff with the latest technologies and tools that help them complete their fieldwork easily
Corporate3 weeks ago
Culture is ranked amongst the top three most important future of work 2021 trends
Corporate3 weeks ago
This year’s IndiaSoft show will have several new facets, keeping in view the focus laid by the government to usher in a digital revolution in the country
Corporate4 weeks ago
MEVP’s new partial exit generated a 52x cash-on-cash multiple and an IRR of over 90 per cent
Corporate1 month ago
Adnoc Distribution is also furthering its commitment to international expansion, with the signing of two new distributors for Adnoc Voyager lubricant in Angola and the Democratic Republic of the Congo
Corporate1 month ago
Mubadala’s $243.4 billion portfolio spans six continents with interests in multiple sectors and asset classes
Corporate1 month ago